Fatih Yetikardes, Country Manager of Daiichi Sankyo, gives insights into advancing patient care with company collaborations, the unique complexities of the Canadian healthcare system, and the ethical use and transparent governance of AI.

Bob McLay, General Manager of Sobi Canada, gives insights into stewarding rare drug therapies, KOL advocacy and the future of preventative medicine.

Marc Shenouda, CEO and Co-Founder of Neuropeutics Inc., gives insights into targeted therapeutics for neurodegenerative disease, winning the AbbVie Biotech Innovator’s Award, and earlier detection for ALS.

Dr. Bettina Hamelin, President of Innovative Medicines Canada, gives insights into the adoption of innovative technologies, domestic supply chain for pharmaceuticals, and excluding medicines as retaliatory measures for tariffs.

Paul Levesque, President and CEO of Theratechnologies Inc., gives insights into innovation in biopharma, the effects of tariffs on supply chain and pharma manufacturing, and cross-border business development.

Mark Nawacki, President and CEO of Searchlight Pharma, gives insights into starting a specialty pharma business, therapeutics for women’s health and migraine relief, and the shift to more personalized medicines in healthcare.

Lisa Mullett, Senior Vice-President of Sumitomo Pharma America, gives insights into the importance of diversity in companies and patient trials, stepping out of your comfort zone to further your career, and accelerating development with AI.

Tom Slowe, CEO of Breadcrumb Analytics, gives insights into using AI to sort and sift through statistics, the importance of context with data, and why AI should only be supplementary to human work.